What a PSA test measures
A PSA test measures prostate-specific antigen, a protein made by normal and abnormal prostate cells, in a small blood sample. MedlinePlus explains that a low level is normal, and that an enlarged prostate, prostate inflammation or prostate cancer can all push it up.
That last point is the reason a PSA result is never a diagnosis on its own. The test cannot tell which of those causes is behind a high number, and only a biopsy can confirm cancer. What PSA does well is flag men who need a closer look and give a baseline to compare against later.
Age-specific PSA reference points
PSA rises naturally as the prostate grows with age, so one cutoff does not fit every man. A Mayo Clinic study of 471 healthy men in Olmsted County, Minnesota, published in JAMA in 1993, set these upper reference limits at the 95th percentile:
| Age | Age-specific upper reference |
|---|---|
| 40 to 49 | 2.5 ng/mL |
| 50 to 59 | 3.5 ng/mL |
| 60 to 69 | 4.5 ng/mL |
| 70 to 79 | 6.5 ng/mL |
The National Cancer Institute adds that no single threshold separates normal from abnormal. In general a PSA above 4.0 ng/mL is treated as abnormal, though some clinicians use a lower cutoff such as 2.5 ng/mL for younger men and a higher one such as 5 ng/mL for older men. Assays and reference ranges differ between labs, so your result is read against the range on your own report.
Why PSA is a gate before TRT
In the TRT pre-screening panel, PSA works as a safety checkpoint rather than a cancer screen. Testosterone can raise PSA and may speed the growth of a small cancer that was already present but undetected, so guidelines want to know where PSA stands before treatment starts.
The Endocrine Society guideline recommends against starting testosterone in men with a PSA above 4 ng/mL, or above 3 ng/mL in men at higher risk, such as Black men or men with a father or brother who had prostate cancer, until a urological evaluation is done. The AUA guideline asks for a PSA in every man over 40 before therapy begins.
The baseline also matters later. The Endocrine Society suggests rechecking PSA 3 to 12 months after starting and referring to urology if PSA climbs more than 1.4 ng/mL within the first year or is confirmed above 4 ng/mL. Without a starting value, neither rule can be applied. Our page on high PSA before starting TRT explains what happens when the gate stays closed.
What can push PSA up or down
Several everyday things move PSA without any cancer present. The NCI lists prostate infection or inflammation and a recent biopsy, which can keep PSA raised for a month or two, along with vigorous exercise such as cycling and ejaculation, which raise it briefly.
Some medicines pull PSA down instead. Finasteride and dutasteride, used for an enlarged prostate or hair loss, lower PSA enough that the result has to be adjusted; see PSA on finasteride for how that works. Our list of what can raise PSA temporarily covers the short-term causes in more depth.
PSA screening outside of TRT
For men not considering testosterone, PSA screening is a personal decision rather than a routine requirement. The U.S. Preventive Services Task Force, in its 2018 recommendation, advises men aged 55 to 69 to decide with their clinician after weighing benefits and harms, and recommends against screening at 70 and older.
MedlinePlus notes that risk runs higher in Black men and in men with a family history of prostate cancer, which may tip the decision toward earlier testing. Our guide on when to start PSA screening lays out the age-by-age options.
How to prepare for a PSA draw
A little preparation keeps a false high off your record. MedlinePlus advises avoiding ejaculation for 24 hours before the test, and the NCI suggests skipping activities that can raise PSA, such as long bike rides, for two days.
Tell your provider if you take finasteride or dutasteride, have had urinary burning or fever recently, or had any prostate procedure in the past few months. If an infection is suspected, the draw is usually postponed until it has cleared.
How Ultimate Male uses your PSA result
PSA is one of four tests in our TRT pre-screening panel, alongside total testosterone, estradiol and a complete blood count, and the panel is bundled with your first consultation. Blood is drawn on site at San Gabriel or Downey, with results back in about 24 to 48 hours.
If your PSA sits within the guideline limits for your age and risk, it becomes the baseline your provider tracks during treatment. If it is above them, the testosterone discussion pauses and you leave with a clear plan for repeat testing or a urology referral. PSA can also be added to a broader workup through our preventative blood testing panels.
